false 0001827075 0001827075 2021-12-22 2021-12-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 22, 2021

 

 

CVENT HOLDING CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39709   98-1560055

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

1765 Greensboro Station Place

7th Floor

Tysons, Virginia

  22102
(Address of principal executive offices)   (Zip Code)

(703) 226-3500

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.0001 par value per share   CVT   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 2.02

Results of Operations and Financial Condition

Set forth below is certain financial information relating to Cvent Holding Corp.’s (“Cvent”) consolidated statements of operations and non-GAAP metrics for each quarter during the fiscal year 2020 and the three months ended March 31 and June 30, 2021.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Non-GAAP Financial Measures

Below we disclose the following non-GAAP financial measures: Non-GAAP Gross Profit, Non-GAAP Sales and Marketing Expenses, Non-GAAP Research and Development Expenses, Non-GAAP General and Administrative Expenses and Adjusted EBITDA.

We believe that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Cvent’s financial condition and results of operations. We use these non-GAAP measures for financial, operational and budgetary decision-making purposes, and to compare our performance to that of prior periods for trend analyses. We believe that these non-GAAP financial measures provide useful information regarding past financial performance and future prospects, and permit us to more thoroughly analyze key financial metrics used to make operational decisions. We believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

We do not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. We urge investors to review the reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures, which are included in this press release, and not to rely on any single financial measure to evaluate our business

Cvent excludes one or more of the following items from these non-GAAP financial measures:

Interest expense. Cvent excludes this expense from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Other income, net. Cvent excludes this item, which is comprised primarily of foreign exchange gains/(losses) and state tax settlements, from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Provision for income taxes. Cvent excludes this item from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Amortization of deferred financing costs and debt discount. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.


Intangible asset amortization. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit and Adjusted EBITDA.

Amortization of software development costs. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit and Adjusted EBITDA.

Stock-based compensation expense. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales and Marketing Expenses, Non-GAAP Research and Development Expenses, Non-GAAP General and Administrative Expenses and Adjusted EBITDA.

Cost related to acquisitions. Cost related to acquisitions is comprised of the value of contingent payments included in compensation expense which relate to the potential cash payment to certain employees of acquired companies whose right to receive such payment is forfeited if they terminate their employment prior to the required service period. As the contingent payments are subject to continued employment, GAAP requires that these payments be accounted for as compensation expense and such expense is subject to revaluation. Additionally, cost related to acquisitions includes expenses related to performing due diligence, valuation, earnouts or other acquisition-related activities. Cvent excludes these expenses primarily because they are not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales and Marketing Expenses, Non-GAAP Research and Development Expenses, Non-GAAP General and Administrative Expenses and Adjusted EBITDA.

Loss on divestitures. Cvent excludes this expense, which is comprised of the loss on the divestiture of Kapow Events in June 2020, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Restructuring expenses. Cvent excludes this expense, which is comprised of expenses associated with severance to terminated employees of acquired entities, retention bonuses to employees retained from acquired entities, the global reduction in force that took place in May 2020 in response to the global COVID-19 pandemic, costs to discontinue use of a back-office system and closing of certain office spaces, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales and Marketing Expenses, Non-GAAP Research and Development Expenses, Non-GAAP General and Administrative Expenses and Adjusted EBITDA.

Other items. Cvent excludes this item, which is comprised of certain expenses associated with litigation, private equity management fees, and credit facility fees, and the net of the gain from government subsidies related to the global COVID- 19 pandemic, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales and Marketing Expenses, Non-GAAP Research and Development Expenses, Non-GAAP General and Administrative Expenses and Adjusted EBITDA.


CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands)

(unaudited)

 

     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

Cost of revenue

     51,961       42,485       39,888       41,916       43,845       45,999  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     87,589       82,673       78,619       73,569       73,442       76,815  

Operating expenses:

            

Sales and marketing

     38,065       32,474       29,004       28,845       28,837       33,070  

Research and development

     25,146       22,875       20,970       18,875       21,674       24,657  

General and administrative

     23,192       20,446       20,243       16,683       16,754       21,600  

Intangible asset amortization, exclusive of amounts included in cost of revenue

     13,457       13,468       13,491       13,428       13,035       12,929  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     99,860       89,263       83,708       77,831       80,300       92,256  

Loss from operations

     (12,271     (6,590     (5,089     (4,262     (6,858     (15,441

Interest expense

     (10,716     (8,828     (8,151     (7,862     (7,533     (7,638

Amortization of deferred financing costs and debt discount

     (953     (951     (948     (946     (943     (941

Loss on divestitures

     —         (9,634     —         —         —         —    

Other income, net

     1,437       20       461       (585     273       3,998  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (22,503     (25,983     (13,727     (13,655     (15,061     (20,022

Provision for income taxes

     2,204       2,018       648       2,995       1,500       1,825  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (24,707   $ (28,001   $ (14,375   $ (16,650   $ (16,561   $ (21,847
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES

(in thousands)

(unaudited)

 

     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

Gross Profit

   $ 87,589     $ 82,673     $ 78,619     $ 73,569     $ 73,442     $ 76,815  

Adjustments

            

Depreciation

     1,528       1,414       1,338       1,225       1,046       966  

Amortization of software development costs

     14,149       14,230       15,154       14,632       15,080       15,149  

Intangible asset amortization

     109       106       111       114       115       65  

Stock-based compensation expense

     155       155       157       (37     59       435  

Restructuring expense

     1       1,337       (98     191       —         2  

Cost related to acquisitions

     13       5       1       —         —         —    

Other items

     41       —         —         (682     (853     (141
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit

   $ 103,585     $ 99,920     $ 95,282     $ 89,012     $ 88,889     $ 93,291  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross Margin:

            

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

Gross Margin

     62.8     66.1     66.3     63.7     62.6     62.5

Non-GAAP Gross Margin

     74.2     79.8     80.4     77.1     75.8     76.0

 

     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

Sales and marketing

   $ 38,065     $ 32,474     $ 29,004     $ 28,845     $ 28,837     $ 33,070  

Adjustments

            

Depreciation

     (743     (701     (636     (694     (445     (404

Stock-based compensation expense

     (1,382     (1,382     (1,397     (1,038     (335     (2,458

Restructuring expense

     (22     (915     107       (211     (24     (7

Cost related to acquisitions

     (111     (43     (40     (36     (35     (30

Other items

     —         —         (151     478       290       90  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Sales and Marketing Expenses

   $ 35,807     $ 29,433     $ 26,887     $ 27,344     $ 28,288     $ 30,261  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Sales and Marketing Expenses as a Percent of Revenue:

            

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

Sales and Marketing Expenses

     27.3     25.9     24.5     25.0     24.6     26.9

Non-GAAP Sales and Marketing Expenses

     25.7     23.5     22.7     23.7     24.1     24.6


     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

Research and Development

   $ 25,146     $ 22,875     $ 20,970     $ 18,875     $ 21,674     $ 24,657  

Adjustments

            

Depreciation

     (730     (719     (714     (743     (516     (506

Stock-based compensation expense

     (1,134     (1,118     (1,125     (763     (141     (1,997

Restructuring expense

     (36     (826     30       (151     18       (33

Cost related to acquisitions

     (135     (81     (18     (14     (6     (3

Other items

     —         —         —         1,421       2,711       655  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Research and Development Expenses

   $ 23,111     $ 20,131     $ 19,143     $ 18,625     $ 23,740     $ 22,773  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Research and Development Expenses as a Percent of Revenue:

            

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

Research and Development Expenses

     18.0     18.3     17.7     16.3     18.5     20.1

Non-GAAP Research and Development Expenses

     16.6     16.1     16.2     16.1     20.2     18.5

 

     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

General and Administrative

   $ 23,192     $ 20,446     $ 20,243     $ 16,683     $ 16,754     $ 21,600  

Adjustments

            

Depreciation

     (1,250     (1,183     (1,010     (513     (1,077     (1,025

Stock-based compensation expense

     (2,176     (2,176     (2,200     (1,374     (73     (2,925

Restructuring expense

     (90     (708     (2,868     (280     (248     (270

Cost related to acquisitions

     (235     (53     (54     (39     (381     (731

Other items

     (1,000     (2,238     (1,013     (1,992     (763     (1,175
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP General and Administrative Expenses

   $ 18,441     $ 14,088     $ 13,098     $ 12,485     $ 14,212     $ 15,474  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

General and Administrative Expenses as a Percent of Revenue:

            

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

General and Administrative Expenses

     16.6     16.3     17.1     14.4     14.3     17.6

Non-GAAP General and Administrative Expenses

     13.2     11.3     11.1     10.8     12.1     12.6


     Three Months Ended  
     March 31,     June 30,     September 30,     December 31,     March 31,     June 30,  
     2020     2020     2020     2020     2021     2021  

Adjusted EBITDA:

            

Net loss

   $ (24,707   $ (28,001   $ (14,375   $ (16,650   $ (16,561   $ (21,847

Adjustments

            

Interest expense

     10,716       8,828       8,151       7,862       7,533       7,638  

Amortization of deferred financing costs and debt discount

     953       951       948       946       943       941  

Loss on divestitures, net

     —         9,634       —         —         —         —    

Other income, net

     (1,437     (20     (461     585       (273     (3,998

Provision for income taxes

     2,204       2,018       648       2,995       1,500       1,825  

Depreciation

     4,251       4,017       3,698       3,175       3,084       2,901  

Amortization of software development costs

     14,258       14,336       15,266       14,746       15,195       15,214  

Intangible asset amortization

     13,457       13,468       13,491       13,428       13,035       12,929  

Stock-based compensation expense

     4,847       4,831       4,879       3,138       608       7,815  

Restructuring expense

     149       3,784       2,634       833       254       312  

Cost related to acquisitions

     494       182       112       89       422       764  

Other items

     1,041       2,238       1,162       (588     (3,091     289  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 26,226     $ 36,266     $ 36,153     $ 30,559     $ 22,649     $ 24,783  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA Margin:

            

Revenue

   $ 139,550     $ 125,158     $ 118,507     $ 115,485     $ 117,287     $ 122,814  

Net loss margin

     -17.7     -22.4     -12.1     -14.4     -14.1     -17.8

Adjusted EBITDA margin

     18.8     29.0     30.5     26.5     19.3     20.2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 22, 2021

 

CVENT HOLDING CORP
By:  

/s/ William J. Newman III

  William J. Newman, III
  SVP, Chief Financial Office
Cvent (NASDAQ:CVT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Cvent Charts.
Cvent (NASDAQ:CVT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Cvent Charts.